Brandes Investment Partners, LP Takeda Pharmaceutical CO LTD Transaction History

Brandes Investment Partners, LP

  • $10.5 Billion
  • Q2 2025

A detailed history of Brandes Investment Partners, LP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Brandes Investment Partners, LP holds 3,712,278 shares of TAK stock, worth $54.3 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
3,712,278
Previous 3,504,142 5.94%
Holding current value
$54.3 Million
Previous $52.1 Million 10.14%
% of portfolio
0.54%
Previous 0.57%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$13.71 - $15.46 $2.85 Million - $3.22 Million
208,136 Added 5.94%
3,712,278 $57.4 Million
Q1 2025

May 15, 2025
BUY
$12.89 - $15.19 $5.99 Million - $7.06 Million
464,557 Added 15.28%
3,504,142 $52.1 Million
Q4 2024

Feb 10, 2025
SELL
$13.01 - $14.43 $2.5 Million - $2.77 Million
-192,019 Reduced 5.94%
3,039,585 $40.2 Million
Q3 2024

Nov 14, 2024
BUY
$13.0 - $15.08 $7.76 Million - $9 Million
596,577 Added 22.64%
3,231,604 $45.9 Million
Q2 2024

Aug 19, 2024
SELL
$12.6 - $13.67 $3.37 Million - $3.66 Million
-267,480 Reduced 9.22%
2,635,027 $34.1 Million
Q1 2024

May 15, 2024
BUY
$13.89 - $15.04 $3.49 Million - $3.78 Million
251,242 Added 9.48%
2,902,507 $40.3 Million
Q4 2023

Feb 09, 2024
BUY
$13.36 - $15.43 $11.3 Million - $13.1 Million
849,229 Added 47.13%
2,651,265 $37.8 Million
Q3 2023

Nov 13, 2023
BUY
$15.03 - $16.32 $551,856 - $599,221
36,717 Added 2.08%
1,802,036 $27.9 Million
Q2 2023

Aug 11, 2023
SELL
$15.57 - $17.11 $819,807 - $900,892
-52,653 Reduced 2.9%
1,765,319 $27.7 Million
Q1 2023

May 10, 2023
BUY
$15.28 - $16.48 $26 Million - $28 Million
1,699,552 Added 1435.19%
1,817,972 $30 Million
Q4 2022

Feb 13, 2023
SELL
$12.42 - $15.62 $21.8 Million - $27.4 Million
-1,752,623 Reduced 93.67%
118,420 $1.85 Million
Q3 2022

Nov 14, 2022
SELL
$12.8 - $28.65 $1.94 Million - $4.34 Million
-151,504 Reduced 7.49%
1,871,043 $24.3 Million
Q2 2022

Aug 12, 2022
SELL
$13.12 - $15.03 $1.15 Million - $1.31 Million
-87,299 Reduced 4.14%
2,022,547 $28.4 Million
Q1 2022

May 10, 2022
BUY
$13.54 - $15.35 $4.88 Million - $5.53 Million
360,083 Added 20.58%
2,109,846 $30.2 Million
Q4 2021

Feb 11, 2022
SELL
$13.17 - $16.4 $3.5 Million - $4.36 Million
-266,061 Reduced 13.2%
1,749,763 $23.9 Million
Q3 2021

Nov 12, 2021
SELL
$16.3 - $17.26 $1.08 Million - $1.15 Million
-66,411 Reduced 3.19%
2,015,824 $33 Million
Q2 2021

Aug 11, 2021
BUY
$16.55 - $18.64 $5.32 Million - $5.99 Million
321,387 Added 18.25%
2,082,235 $35 Million
Q1 2021

May 14, 2021
BUY
$16.71 - $19.9 $1.63 Million - $1.95 Million
97,767 Added 5.88%
1,760,848 $32.3 Million
Q4 2020

Feb 11, 2021
BUY
$15.39 - $18.97 $3.2 Million - $3.95 Million
208,042 Added 14.3%
1,663,081 $30.2 Million
Q3 2020

Nov 12, 2020
SELL
$17.1 - $19.19 $3.69 Million - $4.14 Million
-215,770 Reduced 12.91%
1,455,039 $26 Million
Q2 2020

Aug 12, 2020
SELL
$14.59 - $19.5 $1.86 Million - $2.48 Million
-127,430 Reduced 7.09%
1,670,809 $30 Million
Q1 2020

May 13, 2020
BUY
$13.02 - $20.31 $1.11 Million - $1.72 Million
84,890 Added 4.95%
1,798,239 $27.3 Million
Q4 2019

Feb 13, 2020
SELL
$16.88 - $20.83 $2.19 Million - $2.71 Million
-129,886 Reduced 7.05%
1,713,349 $33.8 Million
Q3 2019

Nov 13, 2019
BUY
$16.15 - $17.99 $8.07 Million - $8.99 Million
499,819 Added 37.21%
1,843,235 $31.7 Million
Q2 2019

Aug 13, 2019
SELL
$16.58 - $20.49 $2.22 Million - $2.74 Million
-133,599 Reduced 9.05%
1,343,416 $23.8 Million
Q1 2019

May 10, 2019
BUY
$16.7 - $21.52 $7.73 Million - $9.97 Million
463,133 Added 45.68%
1,477,015 $30.1 Million
Q4 2018

Feb 11, 2019
BUY
$15.64 - $21.1 $15.9 Million - $21.4 Million
1,013,882 New
1,013,882 $17.1 Million

Others Institutions Holding TAK

# of Institutions
369
Shares Held
73.1M
Call Options Held
1.68M
Put Options Held
157K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $45.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Brandes Investment Partners, LP Portfolio

Follow Brandes Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email